March 29, 2011
The Food and Drug Administration (FDA) has announced the
approval of Uniferon (injectable iron) for the prevention and
treatment of iron deficiency anemia in baby pigs.
The supply of injectable iron dextran products in the United
States in recent years has been inconsistent, according to the FDA,
resulting in shortages.
As a result, FDA determined the product was a medically
necessary drug and issued letters of no objection to certain
approved companies, allowing them to temporarily import and
distribute an injectable 200 mg/ml iron dextran product into the
United States.
"This announcement of the approval of Uniferon should
provide an adequate U.S. domestically manufactured supply and
therefore effectively end any current shortages," FDA
says.
Uniferon 200 (iron dextran 200 mg/ml) is manufactured by
Pharmacosmos, Inc. of Watchung, NJ, and distributed by Ivesco of
Iowa Falls, IA.
For more information regarding pricing and availability of
Uniferon 200, contact Ivesco.
About Uniferon
Uniferon 200 is an iron supplement
for pigs. Manufactured by Pharmacosmos, Uniferon 200 makes iron
administration in your pigs fast and simple.
Pharmacosmos is a leading specialist
in iron therapy and associated pharmaceutical research, and the
company develops, manufactures and markets innovative therapies for
the treatment of iron deficiency in both human and animal
medicine.